JK Dancy Inc. is a technology driven and privately held California corporation, established and self-funded in 1999 solely by the president of JK Dancy, Jim Ktsanes. It has successfully developed and implemented a strategic business plan of market introduction and penetration integrating value-added technology, products, and services for application within the Class III cardiovascular medical device, research, and educational industries.

Although JK Dancy, Inc. is a professional biotech company providing important contracted services to Fortune 100 and 500 companies, as evidenced by its publication,"The 499 Yard News", it still retains the benefits associated with a small but strong, team oriented organization. JK Dancy has participated as an associate exhibitor in the recent STS Exhibit, while providing select companies and consultants with updated press releases and upcoming developments.
As the demand for biological implantables increases, JK Dancy is well positioned to take advantage of the growing market demand for completed and in-process porcine and bovine products.

It is our goal to create and sustain differentiation in the heavily competitive tissue procurement industry. We accomplish this by constantly striving to bring innovative applications and procurement options that are designed to complement your existing ERP systems.

Combining our proprietary tissue selection technique and size categorization method, JK Dancy leverages our integrated efficiencies to deliver real-time products and services allowing our customers to increase their response to sales orders while reducing backlogs and inventory liability. Our products and services can be modified to meet the exacting specifications necessary for seamless integration while improving inventory utilization and material      overhead.